3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
8
Carcinoma
5
Squamous Cell Carcinoma of Head and Neck
3
Recurrence
3
Mouth Neoplasms
3
Colorectal Neoplasms
3
Adenocarcinoma
3
Skin Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell
2
Laryngeal Neoplasms
2
Glioblastoma
2
Fallopian Tube Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Squamous Cell
2
Breast Neoplasms
2
Vaccinia
1
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Sinonasal Squamous Cell Carcinoma
1
Sarcoma
1
Resectable Non-small Cell Lung Cancer
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Interventions
Carboplatin
15
Etoposide
13
atezolizumab
9
Topotecan
8
durvalumab
7
Specimen Handling
7
PM 01183
6
Cisplatin
5
pembrolizumab
4
Magnetic Resonance Spectroscopy
4
Irinotecan
4
Injections
3
Biopsy
3
berzosertib
2
Nivolumab
2
Fulvestrant
2
Drug Therapy
2
AMG 757
2
tremelimumab
1
trastuzumab deruxtecan
1
toripalimab
1
tazemetostat
1
palbociclib
1
olaparib
1
lenvatinib
1
fludarabine
1
enzalutamide
1
cabozantinib
1
budigalimab
1
arginine decarboxylase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
cemiplimab
×
30 days
×
Clear all
No trials found.